Log In
Print
BCIQ
Print
Print this Print this
 

AMR-102, AMR102

  Manage Alerts
Collapse Summary General Information
Company Amarin Corp. plc
DescriptionFixed-dose combination of rosuvastatin and Vascepa icosapent ethyl, a purified form of ethyl ester of eicosapentaenoic acid (ethyl-EPA)
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase I
Standard Indication Cardiovascular (unspecified)
Indication DetailsReduce triglyceride levels
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today